REITER; Yoram

Patent Applications and Registrations

Patent applications and USPTO patent grants for REITER; Yoram.The latest application filed is for "affinity entities comprising a tcr-like antibody binding domain with high affinity and fine specificity and uses of same".

Company Profile

5.28.47

REITER; Yoram - Haifa IL
Reiter; Yoram - Ness Ziona IL

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Affinity Entities Comprising A Tcr-like Antibody Binding Domain With High Affinity And Fine Specificity And Uses Of Same App 20210388111 - PELED KAMAR; Mira ; et al.	2021-12-16
Affinity entities comprising a TCR-like antibody binding domain with high affinity and fine specificity and uses of same Grant 11,001,642 - Peled Kamar , et al. May 11, 2	2021-05-11
Immunotherapeutic Composition For The Treatment Of Cancer App 20200385441 - REITER; Yoram ; et al.	2020-12-10
Antibodies Capable Of Binding Hla-a2/tyrd In An Hla Restricted Manner And Uses Thereof App 20200207858 - Jakobovits; Aya ; et al.	2020-07-02
Chimeric Antigen Receptors And Methods Of Their Use App 20190031759 - REITER; Yoram ; et al.	2019-01-31
T Cell Receptor Like Antibodies Having Fine Specificity App 20180179283 - PELED KAMAR; Mira ; et al.	2018-06-28
Affinity Entities Comprising A Tcr-like Antibody Binding Domain With High Affinity And Fine Specificity And Uses Of Same App 20180171024 - PELED KAMAR; Mira ; et al.	2018-06-21
Fusion Proteins, Uses Thereof And Processes For Producing Same App 20170211076 - REITER; Yoram ; et al.	2017-07-27
Compositions Capable Of Specifically Binding Particular Human Antigen Presenting Molecule/ Antigen Complexes And Uses Thereof App 20170198046 - REITER; Yoram ; et al.	2017-07-13
Isolated high affinity entities with T-cell receptor like specificity towards native complexes of MHC class II and glutamic acid decarboxylase (GAD) autoantigenic peptides Grant 9,695,410 - Reiter , et al. July 4, 2	2017-07-04
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof Grant 9,616,112 - Reiter , et al. April 11, 2	2017-04-11
Antigen-presenting complex-binding compositions and uses thereof Grant 9,095,533 - Reiter , et al. August 4, 2	2015-08-04
Fusion Proteins, Uses Thereof And Processes For Producing Same App 20150152161 - REITER; Yoram ; et al.	2015-06-04
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof Grant 9,023,348 - Reiter , et al. May 5, 2	2015-05-05
Compositions Capable Of Specifically Binding Particular Human Antigen Presenting Molecule/pathogen-derived Antigen Complexes And Uses Thereof App 20150118750 - REITER; Yoram ; et al.	2015-04-30
Antibodies And Their Uses For Diagnosis And Treatment Of Cytomegalovirus Infection And Associated Diseases App 20140363440 - MAKLER; Oryan ; et al.	2014-12-11
Antibodies Which Bind Soluble T-cell Receptor Ligands App 20140170168 - Reiter; Yoram ; et al.	2014-06-19
Anti human immunodeficiency antibodies and uses thereof Grant 8,747,855 - Reiter , et al. June 10, 2	2014-06-10
Method of predicting responsiveness to autologous adoptive cell transfer therapy Grant 8,541,185 - Oved , et al. September 24, 2	2013-09-24
Antibodies With T-cell Receptor Like Specificity Towards Native Complexes Of Mhc Class Ii And Diabetes-associated Autoantigenic Peptides App 20130189284 - Reiter; Yoram ; et al.	2013-07-25
Immuno-molecules containing viral proteins, compositions thereof and methods of using Grant 8,449,889 - Reiter , et al. May 28, 2	2013-05-28
Isolated High Affinity Entities With T-cell Receptor Like Specificity Towards Native Complexes Of Mhc Class Ii And Glutamic Acid Decarboxylase (gad) Autoantigenic Peptides App 20130115218 - Reiter; Yoram ; et al.	2013-05-09
Antibodies And Their Uses For Diagnosis And Treatment Of Cytomegalovirus Infection And Associated Diseases App 20130101594 - MAKLER; Oryan ; et al.	2013-04-25
Antibodies and their uses for diagnosis and treatment of cytomegalovirus infection and associated diseases Grant 8,361,473 - Makler , et al. January 29, 2	2013-01-29
Artificial receptors Grant 8,354,066 - Sivan , et al. January 15, 2	2013-01-15
Immuno-molecules Containing Viral Proteins, Compositions Thereof And Methods Of Using App 20120003249 - REITER; Yoram ; et al.	2012-01-05
Antibody Having A T-cell Receptor-like Specificity, Yet Higher Affinity, And The Use Of Same In The Detection And Treatment Of Cancer, Viral Infection And Autoimmune Disease App 20110318369 - REITER; Yoram ; et al.	2011-12-29
Antigen-presenting complex-binding compositions and uses thereof App 20110293616 - Reiter; Yoram ; et al.	2011-12-01
Immuno-molecules containing viral proteins, compositions thereof and methods of using Grant 8,022,190 - Reiter , et al. September 20, 2	2011-09-20
Fusion proteins, uses thereof and processes for producing same Grant 7,977,457 - Reiter , et al. July 12, 2	2011-07-12
Fusion Proteins, Uses Thereof And Processes For Producing Same App 20110150874 - Reiter; Yoram ; et al.	2011-06-23
Anti Influenza Antibodies And Uses Thereof App 20110033473 - Reiter; Yoram ; et al.	2011-02-10
Anti Human Immunodeficiency Antibodies And Uses Thereof App 20110020357 - Reiter; Yoram ; et al.	2011-01-27
T Cell Subpopulations Capable Of Treating Cancer App 20100310534 - Oved; Kfir ; et al.	2010-12-09
Mhc-peptide Complex Binding Ligands App 20100228007 - HOOGENBOOM; Henricus Renerus Jacobus Mattheus ; et al.	2010-09-09
Antibodies, Methods And Kits For Diagnosing And Treating Melanoma App 20100158927 - Reiter; Yoram ; et al.	2010-06-24
MHC-peptide complex binding ligands Grant 7,718,777 - Hoogenboom , et al. May 18, 2	2010-05-18
Methods Of Diagnosing And Treating Cytomegalovirus Diseases App 20100111957 - Makler; Oryan ; et al.	2010-05-06
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof App 20100080805 - Reiter; Yoram ; et al.	2010-04-01
Antibodies for selective apoptosis of cells App 20100062001 - Reiter; Yoram ; et al.	2010-03-11
Antigen-presenting complex-binding compositions and uses thereof Grant 7,638,124 - Reiter , et al. December 29, 2	2009-12-29
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof Grant 7,632,923 - Reiter , et al. December 15, 2	2009-12-15
Artificial receptors App 20090306578 - Sivan; Uri ; et al.	2009-12-10
Single Chain Class I Major Histocompatibility Complexes, Constructs Encoding Same And Methods Of Generating Same App 20090258393 - REITER; Yoram	2009-10-15
Single chain class I major histocompatibility complexes App 20090148925 - Reiter; Yoram	2009-06-11
Single chain class I major histo-compatibility complexes Grant 7,399,838 - Reiter July 15, 2	2008-07-15
Artificial receptors App 20080076670 - Sivan; Uri ; et al.	2008-03-27
Fusion proteins, uses thereof and processes for producing same App 20080014208 - Reiter; Yoram ; et al.	2008-01-17
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same Grant 7,294,701 - Reiter , et al. November 13, 2	2007-11-13
MHC-peptide complex binding ligands App 20070196369 - Hoogenboom; Henricus Renerus Jacobus Mattheus ; et al.	2007-08-23
Antigen-presenting complex-binding compositions and uses thereof App 20060083735 - Reiter; Yoram ; et al.	2006-04-20
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease Grant 6,992,176 - Reiter , et al. January 31, 2	2006-01-31
Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease App 20050287141 - Reiter, Yoram ; et al.	2005-12-29
Antibody Having A T-cell Receptor-like Specificity, Yet Higher Affinity, And The Use Of Same In The Detection And Treatment Of Cancer, Viral Infection And Autoimmune Disease App 20050255101 - Reiter, Yoram ; et al.	2005-11-17
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof App 20050152912 - Reiter, Yoram ; et al.	2005-07-14
Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer App 20050063970 - Reiter, Yoram ; et al.	2005-03-24
Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same App 20040197334 - Reiter, Yoram ; et al.	2004-10-07
Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof App 20040191260 - Reiter, Yoram ; et al.	2004-09-30
Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same App 20040086960 - Reiter, Yoram	2004-05-06
MHC-peptide complex binding ligands App 20030223994 - Hoogenboom, Henricus Renerus Jacobus Mattheus ; et al.	2003-12-04
Methods and pharmaceutical compositions for immune deception, particularly useful in the treatment of cancer App 20030017134 - Reiter, Yoram ; et al.	2003-01-23
Single chain class I major histo-compatibility complexes App 20030003535 - Reiter, Yoram	2003-01-02
Protease-activatable pseudomonas exotoxin A-like proproteins Grant 6,426,075 - Fitzgerald , et al. July 30, 2	2002-07-30
Polynucleotides encoding protease-activatable pseudomonas exotoxin a-like proproteins Grant 6,423,513 - Fitzgerald , et al. July 23, 2	2002-07-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.